RVL Pharmaceuticals plc Quarterly Accrued Income Taxes, Noncurrent in USD from Q4 2017 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.
Summary
RVL Pharmaceuticals plc quarterly Accrued Income Taxes, Noncurrent history and growth rate from Q4 2017 to Q1 2023.
  • RVL Pharmaceuticals plc Accrued Income Taxes, Noncurrent for the quarter ending March 31, 2023 was $71K, a 5.97% increase year-over-year.
Accrued Income Taxes, Noncurrent, Quarterly (USD)
Accrued Income Taxes, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $71K +$4K +5.97% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $70K +$4K +6.06% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 $70K +$69K +6900% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $68K +$67K +6700% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $67K +$66K +6600% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $66K Dec 31, 2021 10-K 2023-03-20
Q3 2021 $1K Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1K Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $1K Mar 31, 2021 10-Q 2021-05-13
Q3 2019 $2.48M +$412K +19.9% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $2.54M Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $2.54M Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $2.54M +$212K +9.11% Dec 31, 2018 10-K 2020-03-19
Q3 2018 $2.07M Sep 30, 2018 10-Q 2019-11-14
Q4 2017 $2.33M Dec 31, 2017 8-K 2019-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.